Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.

Saved in:
Bibliographic Details
Title: Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.
Authors: Mazewski C; Department of Pediatrics, Children's Healthcare of Atlanta - Egleston, Atlanta, GA., Leary SES; Department of Pediatrics, Seattle Children's, Seattle, WA., Kang G; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN., Li BK; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario., Kellie S; Department of Oncology, Children's Hospital of Westmead Westmead, New South Wales., Hayes L; Department of Radiology, Children's Healthcare of Atlanta - Egleston, Atlanta, GA., Shaw D; Department of Radiology, Seattle Children's, Seattle, WA., Ho B; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario., Reddy A; Department of Neurology, University of California, San Francisco, San Francisco, CA., Gossett J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN., Burger PC; Department of Pathology, Johns Hopkins Hospital, Baltimore, MD., Judkins AR; Department of Pathology, Children's Hospital Los Angeles, Los Angeles, CA., Aridgides P; Department of Radiation Oncology, State University of New York Upstate Medical University, Syracuse, NY., Geyer JR; Department of Pediatrics, Seattle Children's, Seattle, WA., Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Pollack IF; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA., Fouladi M; Department of Pediatrics, Nationwide Children's Hospital Columbus, OH., Huang A; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario.
Source: Neuro-oncology [Neuro Oncol] 2025 Oct 01; Vol. 27 (10), pp. 2726-2737.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noaf132